Bacteriostatic Sodium Chloride Injection, Solution
Product Images NDC 0409-1966

7 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Bacteriostatic Sodium Chloride (NDC 0409-1966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Bacteriostatic 01)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Principal Display Panel (20 mL Vial Label)
Label for Bacteriostatic Sodium Chloride 0.9% Injection, USP, 30 mL multiple-dose vial by Hospira, Inc. The label states it is for drug diluent use only, with a warning that it is not for use in neonates and not for inhalation. Contains sodium chloride 9 mg/mL with benzyl alcohol 9 mg added, sterile and nonpyrogenic. Includes lot and expiration date placeholders.*
FDA Label Image

Tray Ndc 0409-1966-05 (Bacteriostatic 03)

Tray Ndc 0409-1966-05 (Bacteriostatic 03)
Label for Bacteriostatic 0.9% Sodium Chloride Injection, USP, 30 mL multiple-dose fliptop vial. The label indicates the drug is for intramuscular, intravenous, and subcutaneous use, containing 0.9% sodium chloride. It includes warnings such as 'Not for inhalation' and 'Not for use in neonates.' The product is labeled by Hospira, Inc.*
FDA Label Image

Principal Display Panel (10 mL Vial Label)

Principal Display Panel (10 mL Vial Label)
The label for Bacteriostatic 0.9% Sodium Chloride Injection, USP, 10 mL multi-dose vial by Hospira, Inc. Includes warnings such as not for inhalation, not for use in neonates, and specifies use only as a drug diluent. Lists sodium chloride strength as 9 mg/mL with benzyl alcohol 9 mg per mL added, sterile and nonpyrogenic.*
FDA Label Image

Tray Ndc 0409-1966-12 (Bacteriostatic 05)

Tray Ndc 0409-1966-12 (Bacteriostatic 05)
Packaging label for Bacteriostatic 0.9% Sodium Chloride Injection, USP, 10 mL multiple-dose vial by Hospira, Inc. The label includes warnings such as "NOT FOR INHALATION" and "NOT FOR USE IN NEONATES." It notes the product is Rx only and intended for drug diluent use. Storage instructions specify 20 to 25°C (68 to 77°F). The label also mentions preservatives and pH adjusters and features a barcode and lot/expiration date placeholders.*
FDA Label Image

Bacteriostatic 06

Bacteriostatic 06
Label for Bacteriostatic Sodium Chloride 0.9% Sodium Chloride Injection, USP, 20 mL multiple-dose vial. The label states it is for intramuscular, intravenous, or subcutaneous use and warns against inhalation and use in neonates. It is distributed by Hospira, Inc. The label includes lot and expiration placeholders, along with dosage and ingredient details including benzyl alcohol as a preservative.*
FDA Label Image

Bacteriostatic 07

Bacteriostatic 07
The packaging label for Bacteriostatic Sodium Chloride 0.9% Sodium Chloride Injection, USP, 20 mL multiple-dose fliptop vial. The label states it is for intramuscular, intravenous, and subcutaneous use and includes warnings such as 'Not for Inhalation' and 'Not for Use in Neonates.' It is labeled Rx only and distributed by Hospira, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.